Professor Amitava Banerjee

Professor Amitava Banerjee is a distinguished consultant cardiologist based in London who specialises in heart failure, atrial fibrillation, hypertension, breathlessness, and chest pain. In addition to general cardiology, Professor Banerjee is also renowned for his clinical interest in preventive cardiology, data science, and COVID-19. He currently consults privately at Welbeck Heart Health, Chase Lodge Hospital and Barts Health London Private Care, and across two large tertiary care centres: UCL Hospitals NHS Foundation Trust and Barts Health NHS Trust.

Professor Banerjee has cultivated his expertise through extensive training and an impressive array of qualifications. With over 20 years’ clinical experience, he holds a PGCert from the University of Birmingham, a Masters in Public Health from Harvard University, and a DPhil in Epidemiology from the University of Oxford, where he also qualified with an MBBS and an MA (Oxon). Professor Banerjee undertook his medical training as a junior doctor in Oxford, Newcastle, Hull and London, and also completed an internship with the prestigious World Health Organisation in 2005.

In addition to his clinical roles, Professor Banerjee serves in a number of respected senior leadership positions, including as Vice-President (Digital, Marketing and Communication) at the British Cardiovascular Society, Senior Advisor to the World Heart Federation Emerging Leaders Programme, and Trustee at both the South Asian Health Foundation and Long Covid SOS. He is Professor of Clinical Data Science at UCL Institute of Health Informatics. Previously, Professor Banerjee was Clinical Lecturer in Cardiovascular Medicine at the University of Birmingham, from 2011 to 2015.

As a prominent figure in cardiovascular research, Professor Banerjee remained actively engaged in both clinical and academic work throughout the COVID-19 pandemic. He presently spearheads a national study on long COVID (STIMULATE-ICP) with a large platform drug trial, and also has particular insights into global health, evidence-based medicine, and large-scale patient data. Professor Banerjee’s scholarly contributions, which include the publication of more than 270 scientific papers, reflect his long-standing impact in the field of cardiology.